OnKure Therapeutics, Inc. Cash Flow Reinvestment Rate

Latest as of December 2023: 3.10x

OnKure Therapeutics, Inc. cash flow reinvestment rate. OnKure Therapeutics, Inc. (OKUR) has a Cash Flow Reinvestment Rate of 3.10x as of December 2023, reinvesting $29.06 Million (capex $50.00K plus investments $29.01 Million) from operating cash flow of $9.38 Million. Explore OnKure Therapeutics, Inc. (OKUR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

3.10x
(Capex + Investments) / Operating CF

Total Reinvested

$29.06 Million
Capex + Investments

Operating Cash Flow

$9.38 Million
USD

Capital Expenditures

$50.00K
USD

OnKure Therapeutics, Inc. Cash Flow Reinvestment Rate by Year (None–None)

OnKure Therapeutics, Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for OnKure Therapeutics, Inc.. For the full cash flow conversion analysis, see OnKure Therapeutics, Inc. cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow